Skip to main content

Table 2 Summary of the 7 VBDs in this review

From: Addressing vulnerability, building resilience: community-based adaptation to vector-borne diseases in the context of global change

Disease

Vector

Current population affected

Current WHO control/elimination targets

Chagas disease

Triatomine bugs

6 to 7 million, in the Americas

Elimination of peridomiciliary infestation by 2020

Dengue

Aedes mosquitoes

390 million annually. At least 500 000 develop severe dengue, and 2.5% of these die

Reduced rates of morbidity by at least 25% and of mortality by 50% by 2020

Human African trypanosomiasis

Tsetse flies

Estimate of 20 000 new cases (2014), in Africa

Elimination in 80% of foci by 2015 and total elimination by 2020

Leishmaniasis

Phlebotomine sandflies

Over 1.5 million cases, 90% of which are in India, Bangladesh, Sudan, South Sudan, Ethiopia and Brazil

100% case detection and treatment of visceral leishmaniasis in South Asia by 2020

Malaria

Anopheles mosquitoes

214 million cases in 2014 and 438 000 deaths

Reduced incidence and mortality by at least 90% by 2030

Rift Valley Fever

Several mosquito species

Unclear; epidemic-prone zoonotic disease

Unclear

Schistosomiasis

Freshwater snails

Over 200 million people in 2013

Elimination as a public health problem globally by 2025